Ronald Asbury Andrews Insider Trading $OCX OncoCyte Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ronald Asbury Andrews.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ronald Asbury Andrews. Ronald Asbury Andrews is President & CEO in CLARIENT, INC ($CVSN) and President and CEO in CLARIENT, INC ($CVSN) and Director in Precipio, Inc. ($PRPO) and Director in Oxford Immunotec Global PLC ($OXFD) and CEO and President in OncoCyte Corp ($OCX) and Chief Executive Officer in OncoCyte Corp ($OCX) and Director in OncoCyte Corp ($OCX).
Ronald Asbury Andrews in OncoCyte Corp
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Ronald Asbury Andrews: CEO and President, Chief Executive Officer, Director
Holdings: 113,698 shares
Current Value: $619,654
Latest Transaction: Mar 22 2021
$OCX Market Capitalization: $159.33M
$OCX Previous Close: $5.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ronald Asbury Andrews in OncoCyte Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CVSN, OCX, OXFD, PRPO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Buy | P | 4.79 | 11,000 | 52,702 | 113,698 | 102.7 K to 113.7 K (+10.71 %) |
| Aug 04 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Buy | P | 1.35 | 40,000 | 53,880 | 102,698 | 62.7 K to 102.7 K (+63.80 %) |
| May 12 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Option Exercise | A | 0.00 | 106,221 | 0 | 106,221 | |
| Apr 01 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | CEO and President | Buy | P | 2,372.00 | 18,000 | 42,696,000 | 62,698 | 44.7 K to 62.7 K (+40.27 %) |
| Apr 01 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | CEO and President | Buy | P | 2.26 | 27,216 | 61,454 | 44,698 | 17.5 K to 44.7 K (+155.68 %) |
| Jul 03 2019 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Option Exercise | A | 2.51 | 950,000 | 2,384,500 | 950,000 | |
| Sep 04 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 2.40 | 45,000 | 108,000 | 45,000 | |
| Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Option Exercise | P | 3.00 | 17,482 | 52,446 | 17,482 | |
| Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Buy | P | 0.00 | 17,482 | 0 | 17,482 | 0 to 17.5 K |
| Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Option Exercise | P | 3.00 | 17,482 | 52,446 | 17,482 | |
| Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Buy | P | 0.00 | 17,482 | 0 | 17,482 | 0 to 17.5 K |
Page: 1